Tian An China Investments Company Limited announced that Pursuant to Rule 13.49(1) of the Listing Rules, the Company is required to publish an announcement for the 2023 Annual Results on a date not later than three months after the end of the financial year of the Company, namely, on or before 31 March, 2024. Under Rule 13.49(2) of the Listing Rules, the preliminary announcement in relation to the 2023 Annual Results shall be based on the Group's consolidated financial statements for the financial year ended 31 December, 2023 which shall have been agreed with the Company's auditor. The acquisition of China Medical & HealthCare Group Limited ("CMH") by a wholly-owned subsidiary of the Company on 5 October, 2023 requires the consolidation of the audited accounts of CMH into the Company.

Prior to the Acquisition, CMH was not a subsidiary of another listed company and did not have to prepare a consolidation package, which took the finance team of CMH longer than expected to complete the consolidation packages for both the period ended on the date of the Acquisition and for the year ended at 31 December, 2023. The delay was compounded by the change of auditors by CMH in December 2023. The delay in the Publication is caused solely by the time required to complete the Consolidation.

As at the date of this announcement, a substantial portion of the information for the purpose of the Consolidation had been provided by CMH. The Company will work closely with its auditor to finalise the audit of the 2023 Annual Results. Having considered the work required in the Consolidation, and after consulting the auditor of the Company, the Board is of the view that the Publication can be made on 12 April, 2024.